Loading...

Ariele Greenfield, MD

Title(s)Research Associate, Neurology
SchoolSchool of Medicine
Phone415-353-2069
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Biography 
    Collapse Education and Training
    UCSFFellowship06/2019Neuroimmunology & Multiple Sclerosis, Translational Research + Clinical Fellowship
    UCSFResidency06/2015Neurology
    UCSDInternship06/2012Internal Medicine
    UCSDMD06/2011Medicine
    UCLABS06/2007Neuroscience
    Collapse Awards and Honors
    National Multiple Sclerosis Society2016  - 2019Clinician-Scientist Development Award, Kathleen C. Moore Postdoctoral Fellowship
    American and European Committees for Treatment and Research in Multiple Sclerosis20177th Joint Congress Poster Prize Shortlist
    Scienion AG2017Idea Pitch Competition 1st Place
    American Academy of Neurology2011Student Prize for Excellence in Neurology
    UCLA2007Highest Honors in Neuroscience

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Gelfand JM, Greenfield AL, Barkovich M, Mendelsohn BA, Van Haren K, Hess CP, Mannis GN.Allogeneic HSCT for Adult-Onset Leukoencephalopathy with Spheroids and Pigmented Glia (in press). Brain. 2019.
    2. Greenfield AL, Hauser SL. Nucleic Acid-Based Therapeutics Relevant to Neuroimmune Conditions. Neurotherapeutics. 2019 04; 16(2):314-318. PMID: 31087242.
      View in: PubMed
    3. Greenfield AL, Dandekar R, Ramesh A, Eggers EL, Wu H, Laurent S, Harkin W, Pierson NS, Weber MS, Henry RG, Bischof A, Cree BA, Hauser SL, Wilson MR, von Büdingen HC. Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis. JCI Insight. 2019 Mar 21; 4(6). PMID: 30747723.
      View in: PubMed
    4. Greenfield AL, Hauser SL. B-cell Therapy for Multiple Sclerosis: Entering an era. Ann Neurol. 2018 01; 83(1):13-26. PMID: 29244240.
      View in: PubMed
    5. Eggers EL, Michel BA, Wu H, Wang SZ, Bevan CJ, Abounasr A, Pierson NS, Bischof A, Kazer M, Leitner E, Greenfield AL, Demuth S, Wilson MR, Henry RG, Cree BA, Hauser SL, von Büdingen HC. Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients. JCI Insight. 2017 11 16; 2(22). PMID: 29202449.
      View in: PubMed
    6. H.-Christian von Büdingen, Feng Mei, Ariele Lauren Greenfield, Sarah Jahn, Yun-An Shen, Hugh Reid, David McKemy, Jonah R. Chan. The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry. Journal of Experimental Medicine. 2015 Sep 21; 212(10):21210oia76.
      View in: Publisher Site
    7. von Büdingen HC, Mei F, Greenfield A, Jahn S, Shen YA, Reid HH, McKemy DD, Chan JR. The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry. J Cell Biol. 2015 Sep 14; 210(6):891-8. PMID: 26347141.
      View in: PubMed